The Evolving Landscape of Liver Cirrhosis Management


Book Description

This book comprehensively covers the latest developments in the diagnosis and treatment of liver cirrhosis, including molecular mechanisms and therapeutic strategies. It elaborates on and explores the relation between chronic liver disease (CLD) and its causes, including viral hepatitis, steatohepatitis, autoimmune liver diseases and/or inherited liver diseases, and sustained liver injury. Furthermore, it discusses various complications such as hepatic encephalopathy, ascites, sarcopenia, esophagogastric varices, muscle cramps and pruritus, and the fact that it frequently leads to the development of hepatocellular carcinoma. CLD is becoming a growing issue with substantial effects on public health, and Evolving Landscape in Management of Liver Cirrhosis provides scholars in gastroenterology and hepatology with invaluable insights. At the same time, it is a valuable resource for clinicians specializing in gastroenterology and hepatology as well as for researchers who are curious about new research on liver disease.




Immunotherapy of Hepatocellular Carcinoma


Book Description

In this book we provide insights into liver – cancer and immunology. Experts in the field provide an overview over fundamental immunological questions in liver cancer and tumorimmunology, which form the base for immune based approaches in HCC, which gain increasing interest in the community due to first promising results obtained in early clinical trials. Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death in the United States. Treatment options are limited. Viral hepatitis is one of the major risk factors for HCC, which represents a typical “inflammation-induced” cancer. Immune-based treatment approaches have revolutionized oncology in recent years. Various treatment strategies have received FDA approval including dendritic cell vaccination, for prostate cancer as well as immune checkpoint inhibition targeting the CTLA4 or the PD1/PDL1 axis in melanoma, lung, and kidney cancer. Additionally, cell based therapies (adoptive T cell therapy, CAR T cells and TCR transduced T cells) have demonstrated significant efficacy in patients with B cell malignancies and melanoma. Immune checkpoint inhibitors in particular have generated enormous excitement across the entire field of oncology, providing a significant benefit to a minority of patients.




Changing landscape of Heart failure imaging, An Issue of Heart Failure Clinics, An Issue of Heart Failure Clinics, E-Book


Book Description

In this issue of Heart Failure Clinics, guest editor Dr. Purvi Parwani brings her considerable expertise to the topic of the Changing Landscape of Heart Failure Imaging. Top experts cover the latest updates in heart failure imaging; imaging in HCM: beyond risk stratification; aortic stenosis: advanced Imaging parameters and the changing treatment landscape; mitral regurgitation: advanced Imaging parameters and the changing treatment landscape; heart failure preserved EF in women; and more. - Contains 12 relevant, practice-oriented topics including artificial intelligence in heart failure imaging; ischemic cardiomyopathy: imaging-guided therapies; evaluation and management of cardiac sarcoidosis with advanced imaging; viral myocarditis and dilated cardiomyopathy: changing diagnostic insight from advanced imaging; and more. - Provides in-depth clinical reviews on the changing landscape of heart failure imaging, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.




Autoimmune Hepatitis: Unraveling the Complexities of Immunology, Liver Health, and Holistic Care


Book Description

Could autoimmune hepatitis be the hidden cause behind chronic liver inflammation? Dive into this essential guide to understand the complexities of Autoimmune Hepatitis (AIH). CLARIFIES AIH CAUSES & PATHOGENESIS: Uncover how the immune system mistakenly targets the liver, leading to chronic inflammation. DIFFERENTIATES AIH SUBTYPES: Learn about the two main AIH types and their distinct markers and characteristics. SYMPTOMS & DIAGNOSTIC TECHNIQUES: Discover the tools and tests that help accurately diagnose AIH. IN-DEPTH TREATMENT INSIGHTS: Explore current and emerging therapies to manage this challenging autoimmune disease. HISTORICAL AND GENETIC PERSPECTIVES: Understand the genetic predispositions and milestones shaping AIH knowledge. This book provides a comprehensive view of autoimmune hepatitis, covering the underlying immune mechanisms, diagnostic strategies, and tailored treatments. Perfect for healthcare professionals and patients alike, it offers insights into managing AIH effectively while promoting liver health and understanding the disease’s progression.




The Changing Landscape of IBD


Book Description

In the past 2 decades, the introduction of biologic therapies that target underlying disease processes has dramatically changed the treatment of the inflammatory bowel diseases (IBDs), ulcerative colitis and Crohn’s disease. Current biologic therapy with tumor necrosis factor inhibitors and anti-integrins has improved the treatment of IBD flares and maintenance of clinical remission. These agents are, however, limited by primary nonresponse and loss of response in a substantial proportion of patients, disease relapse after cessation of therapy, immunogenicity, and adverse effects such as risk for infection and malignancy. As the pathogenesis and treatment of IBD are complex and variable, there is a need to better understand the underlying pathogenic mechanisms and develop drug therapies to target these mechanisms. Geared to the needs of gastroenterologists, this IBD eHealth program includes an update on patient assessment and treat-to-target goals, as well as a review of best practices in shared decision-making in treatment decisions for induction and maintenance of remission. In addition, the immunopathogenesis of IBD is discussed in the context of current and emerging targeted therapies for moderate to severe disease.




Drug-Induced Liver Injury


Book Description

Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. - Includes the authority and expertise of leading contributors in pharmacology - Presents the latest release in the Advances in Pharmacology series




Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics - E-Book


Book Description

**Selected for Doody's Core Titles® 2024 with "Essential Purchase" designation in Laboratory Technology** Master clinical lab testing skills with the condensed version of the Tietz Textbook! Designed for use by CLS students, Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics, 9th Edition provides a streamlined guide to the clinical chemistry knowledge you need to work in a real-world, clinical lab. Coverage ranges from laboratory principles to analytical techniques and instrumentation, analytes, pathophysiology, and more. New content keeps you current with the latest developments in molecular diagnostics. From highly respected clinical chemistry educator Nader Rifai, this textbook shows how to select and perform diagnostic lab tests, and how to accurately evaluate results. - Coverage of analytical techniques and instrumentation includes optical techniques, electrochemistry, electrophoresis, chromatography, mass spectrometry, enzymology, immunochemical techniques, microchips, automation, and point of care testing. - Authoritative, foundational content mirrors that in the Tietz "bible" of laboratory medicine but in a more concise way. - Updated chapters on molecular diagnostics cover the principles of molecular biology, nucleic acid techniques and applications, and genomes and nucleic acid alterations, reflecting the changes in this rapidly evolving field. - Clinical cases from the Coakley Collection demonstrate how concepts from the text are applied in real-life scenarios. - More than 400 illustrations and easy-to-read summary tables help you better understand and remember key concepts. - Learning objectives, key words with definitions, and review questions are included in each chapter to make learning easier. - NEW! Updated content throughout the text keeps you up to date on the latest techniques, instrumentation, and technologies. - NEW! Additional questions are added to each chapter for subject reinforcement. - NEW! Access to Adaptive Learning courses in clinical chemistry and molecular diagnostics is provided on the Evolve website.




Variceal Bleeding in Liver Cirrhosis


Book Description

This book discusses the management of variceal bleeding in liver cirrhosis, covering a wide range of topics, including epidemiology, mechanism, diagnosis and monitoring, prophylaxis, treatment, and prognostic assessment. It also presents the latest research in the field, such as non-invasive approaches, self-expanding metal stents, hemostatic powder, and early TIPS. The book is a valuable resource for physicians wanting to establish standard treatment strategies, researchers launching innovative clinical and experimental studies, and also for patients and their relatives wishing to gain a better understanding of this disease.




Alcohol-Associated Liver Disease, An Issue of Clinics in Liver Disease, E-Book


Book Description

In this issue of Clinics in Liver Disease, guest editor Dr. Ashwani K. Singal brings his considerable expertise to the topic of Alcohol-Associated Liver Disease. Portal hypertension is often one of the major complications seen in advanced liver disease. Top experts discuss various aspects of alcohol-associated liver disease (ALD), to provide comprehensive coverage on current status, update recent developments especially during the last decade, and highlight clinical and experimental unmet needs for practicing providers and for researchers in the field of ALD. - Contains 18 relevant, practice-oriented topics including microbiome in ALD; diagnosis of alcoholic use disorder and of ALD; non-invasive tests in assessment of ALD patients; treatment of alcoholic use disorder: behavioral and pharmacological therapies; current medical treatment of ALD: pharmacological and nutrition; liver transplantation in ALD; digital technology and AI in management of ALD; and more. - Provides in-depth clinical reviews on alcohol-associated liver disease, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.




Hepatocellular Carcinoma: Moving into the 21st Century , An Issue of Clinics in Liver Disease E-Book


Book Description

In collaboration with Consulting Editor, Dr. Norman Gitlin, Guest Editor Dr. Catherine Frenette has assembled expert authors to provide current updates on Hepatocellular Carcinoma (HCC). This issue asks important questions and provides answers and current thoughts on the staging and treatment of HCC. Clinical review articles are specifically dedicated to the following topics: The Changing Global Epidemiology of Hepatocellular Carcinoma; Prevention Strategies for HCC; Biomarkers or Biopsy for Diagnosis of HCC; Screening and Surveillance Strategies to Improve the Chance of Success; Imaging Diagnosis of HCC; Surgical Resection: Old dog--Any new tricks; Hepatocellular Carcinoma and Liver Transplant: How Will Organ Allocation Changes Affect the HCC Patient Within Transplant Criteria; Downstaging to Liver Transplant: Success Involves Choosing the Right Patient; Locoregional Therapies for Hepatocellular Carcinoma: What has Changed in the Past Ten Years; External Beam Radiotherapy: Is There a Place for This in HCC Treatment; Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma; Immuno-oncology for Hepatocellular Carcinoma: The Present and the Future; Management of Side Effects of Systemic Therapies for HCC: Guide for the Hepatologist; and Why a Multi-disciplinary Tumor Board is Critical for Success with Hepatocellular Carcinoma. Readers will come away with the information they need to improve patient outcomes in the patient with HCC.